Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Aussie Senate Approves Bill To Cut Drug Costs By U.S.$2 Billion

This article was originally published in PharmAsia News

Executive Summary

Australia's Senate approved legislation designed to trim nearly US$2 billion from the nation's medicine costs

Australia's Senate approved legislation designed to trim nearly US$2 billion from the nation's medicine costs.

A deal with drug makers operating in the country promised a reduction in the price of some drugs that have lost patent protection. Medicines Australia negotiated the deal with drug makers on behalf of the Pharmaceutical Benefits Scheme. Under a compromise that led to final passage, the bill calls for including the generics industry in future price negotiations. (Click here for more)

"New Medicine Pricing To Save $2 Billion"- ABC News (Australia) (11/23/10)

Latest Headlines
See All
UsernamePublicRestriction

Register

SC073623

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel